Your Article Summary
Cardiac Amyloidosis Treated with an Implantable Cardioverter Defibrillator and Subcutaneous Array Lead System: Report of a Case and Literature Review
Clinical Cardiology, 05/28/09
Dhoble A et al. - A subcutaneous array lead system is useful in reducing the DFT, and can terminate ventricular tachycardia or fibrillation by allowing more energy delivery and efficient defibrillation.
Related Articles
Pseudomembranous Aspergillus tracheobronchitis in a heart transplant recipient
Transplant Infectious Disease, 10/27/09
Relevance Score: 64%
Persistent Troponin Elevation in a Patient with Cardiac Amyloidosis
Clinical Cardiology, 10/21/09
Relevance Score: 64%
Prevention of Amyloidosis in Familial Mediterranean Fever with Colchicine: A Case-Control Study in Armenia
Medical Principles and Practice, 10/05/09
Relevance Score: 47%
Long-term cardiac follow-up of children treated with anthracycline doses of 300 mg/m2 or less for acute lymphoblastic leukemia
Pediatric Blood & Cancer, 10/29/09
Relevance Score: 46%
Evaluation of a Novel Integrated Sensor System for Synchronous Measurement of Cardiac Vibrations and Cardiac Potentials
The Journal of Medical Systems, 10/19/09
Relevance Score: 46%
Today in Amyloidosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Amyloid and the GI tract
Expert Review of Gastroenterology & Hepatology, 12/03/09
MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations
Rheumatology International, 10/16/09
Classification of amyloidosis by laser microdissection and mass spectrometry based proteomic analysis in clinical biopsy specimens
Blood, 10/09/09

See Latest Articles